# Forensic Dossier: Study Forensics: Amyloid-targeting antibody improves biomarkers without cognitive benefit

**Run ID:** `praxis_study-forensics-029_Claude_Opus_ca981f`  
**Task:** study-forensics-029 | study_forensics | medium | study_forensics  
**Timestamp:** 2026-04-07T07:56:17.840669+00:00  
**Task Family:** solid  
**Trap Type:** borderline_solid_with_caveats  
**Ambiguity:** medium  

## Executive Summary

**Agents tested:** Claude Opus
**Winner:** Claude Opus — **72.6/100** (margin: 0.0)
**Failure modes:** named_not_explained, unsupported_conclusion, unsupported_intermediate_step
**Forensic flags:** 5
**Consistency findings:** 7
**Answer convergence:** all agents agree

## Score Matrix

| Agent | Correctness | Support Strength | Structural Reaso | Assumption Disci | Uncertainty Hand | Alternative Hypo | Self Monitoring  | Insight Depth | Mechanism Qualit | Communication Ef | **Total** |
|-------|-------|-------|-------|-------|-------|-------|-------|-------|-------|-------|-------|
| Claude Opus | 30.0/30 | 0.0/8 | 4.8/8 | 4.8/6 | 3.9/6 | 6.0/6 | 3.6/8 | 8.0/8 | 1.5/10 | 10.0/10 | **72.6/100** |

## Study Forensics Audit

### Claude Opus

**Classification:** `solid` [+] (gold: `solid`)
**Finding Recall:** 100%
**Matched Findings:** evidence_matches_claim, cautious_scope_control
**Extra Findings:** none_or_minor, conclusion_exceeds_results, mechanism_not_demonstrated, correlation_as_causation

## Reasoning Integrity Audit

### Claude Opus
**Classification:** Correct but brittle reasoning
**Load-bearing steps:** 0 / 6

## Mechanism Analysis

### Claude Opus
| Aspect | Status |
|--------|--------|
| Concept named | :white_check_mark: effect |
| Mechanism described | :x: (0 sentence(s)) |
| Grounded to case | :x: (0 sentence(s)) |

**Missing:** mechanism not described, mechanism not grounded to case data

## Grounding Audit

### Claude Opus
Conclusion claims: 1
- Direct support: 0
- Indirect support: 0
- Unsupported: 1
- Contradicted: 0

**Unsupported claims:**
- "solid"


## Forensic Flags

### Claude Opus

- **[MODERATE]** `weak_mechanism`: Correct answer but weak mechanism explanation — answer may not generalize
  - `final_answer`: "solid"
- **[MAJOR]** `unsupported_leap`: Correct answer with weak support chain — final answer may be an unsupported leap
- **[MODERATE]** `unsupported_conclusion_claims`: 1/1 conclusion claims lack step support
  - `final_answer`: "solid"
- **[MODERATE]** `ungrounded_mechanism`: Mechanism named/described but not connected to case-specific data
  - `(mechanism analysis)`: "effect"
- **[MINOR]** `study_forensics_overflagging`: Agent raised extra findings in solid case: none_or_minor, conclusion_exceeds_results, mechanism_not_demonstrated, correlation_as_causation


## Evidence Map

### Claude Opus

**Correctness:** 30.0/30
  - (+) `final_answer`: "solid"
    _Agent's answer for correctness check_
  - Note: Exact match

**Support Strength:** 0.0/8
  - (-) `final_answer`: "solid"
    _Conclusion not supported by steps_
  - Note: Support classification: 0 load-bearing, 0 supporting, 0 mentioned / 6
  - Note: Reasoning graph: conclusion not well grounded

**Structural Reasoning:** 4.8/8
  - (+) `steps[1]`: "The results are clearly stated: positive effects on biomarkers (amyloid deposits, neurodegeneration markers) but no effe"
    _Most informative reasoning step_
  - Note: 6 reasoning steps
  - Note: Low step utility: 0/6 steps contribute

**Assumption Discipline:** 4.8/6
  - (+) `assumptions[2]`: "The investigators accurately reported both positive biomarker results and negative cognitive results"
    _Most substantive assumption_
  - Note: 4/4 substantive assumptions

**Uncertainty Handling:** 3.9/6
  - (+) `uncertainties[0]`: "Whether the investigators made stronger claims in the actual paper that aren't reflected in this summary"
    _Most substantive uncertainty_
  - (+) `confidence`: "confidence: 0.85"
    _Stated confidence level_
  - Note: 3 uncertainties (3 substantive)
  - Note: Confidence 0.85

**Alternative Hypothesis Quality:** 6.0/6
  - (+) `alternative_hypotheses[0]`: "Could be classified as 'mechanism_vs_evidence' if the investigators were implying biomarker changes should translate to "
    _Most substantive alternative hypothesis_
  - Note: 2 alternative hypotheses considered
  - Note: 2/2 include rejection reasoning

**Self Monitoring Quality:** 3.6/8
  - (+) `self_check[3]`: "The investigators' emphasis on biomarkers could be problematic if taken out of context, but with their acknowledgment of"
    _Most substantive self-verification step_
  - (-) `self_check[1]`: "Is there any actual overclaim? No - they acknowledge the key limitation"
    _Fluff self-check_
  - Note: 4 self-check items
  - Note: Self-check quality: 0 deep, 3 arithmetic, 1 fluff

**Mechanism Quality:** 1.5/10
  - Note: Names concept but does not describe mechanism

**Communication Efficiency:** 10.0/10
  - Note: Signal density: 0.69, 337 words

**Insight Depth:** 8.0/8
  - Note: Key insights: 2 full / 2


## Failure Analysis

### Claude Opus

**MODERATE:**
- **Unsupported Conclusion** `[MEDIUM CONFIDENCE]`: Final answer lacks load-bearing or supporting step grounding
  - `final_answer`: "solid"
  - _Impacts: support_strength_
- **Named Not Explained** `[MEDIUM CONFIDENCE]`: Names the phenomenon but does not explain the causal mechanism
  - `final_answer`: "solid"
  - _Impacts: mechanism_quality_
- **Named Not Explained** `[MEDIUM CONFIDENCE]`: Named concept(s) ['effect'] but mechanism not described
  - _Impacts: mechanism_quality, insight_depth_
- **Unsupported Intermediate Step** `[MEDIUM CONFIDENCE]`: No reasoning step is load-bearing — final answer lacks traceable derivation
  - `final_answer`: "solid"
  - _Impacts: support_strength, structural_reasoning_


## Consistency & Grounding Audit

### Claude Opus

- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 1 has low overlap with final answer (0/9 content words)
  - `key_claims[0]`: "The study appropriately tested both mechanistic (biomarkers) and clinical (cognitive) outcomes"
- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 2 has low overlap with final answer (0/10 content words)
  - `key_claims[1]`: "The investigators honestly reported negative clinical results despite positive biomarker findings"
- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 3 has low overlap with final answer (0/9 content words)
  - `key_claims[2]`: "The acknowledgment that 'cognitive benefits remain unproven' shows appropriate epistemic restraint"
- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 4 has low overlap with final answer (0/8 content words)
  - `key_claims[3]`: "This represents good scientific practice - reporting all results, not just positive ones"
- **[WARN]** `[HEURISTIC]` `claim_step_alignment`: Key claim 1 not well supported in reasoning steps (1/9 content words found)
  - `key_claims[0]`: "The study appropriately tested both mechanistic (biomarkers) and clinical (cognitive) outcomes"
- **[WARN]** `[HEURISTIC]` `claim_step_alignment`: Key claim 4 not well supported in reasoning steps (1/8 content words found)
  - `key_claims[3]`: "This represents good scientific practice - reporting all results, not just positive ones"
- **[WARN]** `[MEDIUM CONFIDENCE]` `mechanism_gap`: Phenomenon is named but causal mechanism is not explained
  - `final_answer`: "solid"


## Agent Profiles

### Claude Opus (claude-opus-4-20250514)
**Parse OK:** True | **Latency:** 19374ms

**Final Answer:** solid

**Confidence:** 0.85

**Assumptions:**
- This is a randomized Phase 2/3 trial with appropriate controls
- The trial measured both biomarkers and cognitive outcomes
- The investigators accurately reported both positive biomarker results and negative cognitive results
- The text accurately represents what the investigators claimed

**Reasoning Steps:**
1. The study design appears appropriate - randomized Phase 2/3 trial for testing a therapeutic intervention
2. The results are clearly stated: positive effects on biomarkers (amyloid deposits, neurodegeneration markers) but no effect on cognitive decline
3. The investigators' response is measured - they emphasize the biomarker success but explicitly acknowledge lack of cognitive benefits
4. No causal claims are made beyond what the evidence supports
5. The proposal for an open-label extension is a reasonable next step given mixed results
6. The text does not make overclaims about the drug's effectiveness for treating Alzheimer's symptoms

**Key Claims:**
- The study appropriately tested both mechanistic (biomarkers) and clinical (cognitive) outcomes
- The investigators honestly reported negative clinical results despite positive biomarker findings
- The acknowledgment that 'cognitive benefits remain unproven' shows appropriate epistemic restraint
- This represents good scientific practice - reporting all results, not just positive ones

**Alternative Hypotheses:**
- Could be classified as 'mechanism_vs_evidence' if the investigators were implying biomarker changes should translate to cognitive benefits, but the text indicates they acknowledged this disconnect
- Could be 'overclaim' if they were promoting the drug despite lack of clinical benefit, but they explicitly state cognitive benefits remain unproven

**Uncertainties:**
- Whether the investigators made stronger claims in the actual paper that aren't reflected in this summary
- The specific language used in proposing the open-label extension - was it appropriately cautious?
- Whether 'emphasized' implies they gave undue weight to biomarker results over clinical outcomes

**Self-Verification:**
- Did I look for problems that aren't there? The text shows investigators being transparent about mixed results
- Is there any actual overclaim? No - they acknowledge the key limitation
- Am I being influenced by the common pattern of Alzheimer's drug failures? Focusing only on what's in this text
- The investigators' emphasis on biomarkers could be problematic if taken out of context, but with their acknowledgment of unproven cognitive benefits, this appears balanced

**Dimension Scores:**
- Correctness: 30.0/30 `##########`
- Support Strength: 0.0/8 `..........`
- Structural Reasoning: 4.8/8 `######....`
- Assumption Discipline: 4.8/6 `########..`
- Uncertainty Handling: 3.9/6 `######....`
- Alternative Hypothesis Quality: 6.0/6 `##########`
- Self Monitoring Quality: 3.6/8 `####......`
- Insight Depth: 8.0/8 `##########`
- Mechanism Quality: 1.5/10 `#.........`
- Communication Efficiency: 10.0/10 `##########`


## Final Verdict

**Solo run: Claude Opus** scored **72.6/100**.

**Best per dimension:**
- Correctness: Claude Opus (30.0/30)
- Support Strength: Claude Opus (0.0/8)
- Structural Reasoning: Claude Opus (4.8/8)
- Assumption Discipline: Claude Opus (4.8/6)
- Uncertainty Handling: Claude Opus (3.9/6)
- Alternative Hypothesis Quality: Claude Opus (6.0/6)
- Self Monitoring Quality: Claude Opus (3.6/8)
- Insight Depth: Claude Opus (8.0/8)
- Mechanism Quality: Claude Opus (1.5/10)
- Communication Efficiency: Claude Opus (10.0/10)

**Latency vs Quality:**

| Agent | Latency | Score | Points/sec |
|-------|---------|-------|------------|
| Claude Opus | 19.4s | 72.6/100 | 3.7 |

Failure modes observed: named_not_explained, unsupported_conclusion, unsupported_intermediate_step.
